VEEV

As of 2026-10-26, VEEV scores 65out of 100 on QNTM’s five-factor quantitative model, a high conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. VEEV trades at $318.18, 19% above the band ceiling.

VEEV scores 65 out of 100 on QNTM's five-factor model — a high-conviction reading — 65 puts it among the strongest factor profiles the model tracks. Its strongest factor is momentum at 90 (exceptional), where price trend and relative strength are working in its favor, followed by quality at 60. The weakest is sentiment at 51, where sentiment signals are working against it. Among Healthcare stocks it ranks in roughly the top 4% of the Healthcare names the model scores.

On valuation, VEEV is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 66. Same-sector names the model rates nearby include HALO, THC, CON.

This is a descriptive factor read on VEEV, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where VEEV sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for VEEV runs $165.80–$266.60. Current price $318.18 sits 19% above the band ceiling. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-10-26.